Overview
GUTS market data
Price History
GUTS price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for GUTS. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Fractyl Health Helps Maintain Weight After Stopping Popular Obesity Drugs, Stock SoarsBenzinga · Jul 15, 2026, 6:22 PM
Fractyl Health shares are trading higher after the company announced randomized data from REMAIN-1 Midpoint Cohort demonstrating durable weight maintenance one year after GLP-1 discontinuation.Benzinga · Jul 15, 2026, 6:21 PM
Fractyl Health Announces One-Year Results From Its REMAIN-1 Midpoint Cohort; Results Reinforce Potential Of Revita DMR System To Become First Durable Therapy For Post-GLP-1 Weight MaintenanceBenzinga · Jul 15, 2026, 10:02 AM
8-K filing — FRACTYL HEALTH, INC. (GUTS)SEC EDGAR · Jul 15, 2026, 10:00 AM
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price TargetBenzinga · Jun 4, 2026, 4:55 PM
Fractyl Health Announces 1-Yr Results From Open-Label REVEAL-1 Cohort; Participants Retained ~78% Of GLP-1 Induced Total Body Weight Loss One Year After Discontinuation And Single Revita ProcedureBenzinga · Jun 4, 2026, 11:10 AM
Fractyl Health shares are trading higher after the company reported better-than-expected Q1 EPS results.Benzinga · May 13, 2026, 3:37 PM
Fractyl Health Q1 EPS $0.06 Beats $(0.16) EstimateBenzinga · May 12, 2026, 8:15 PM
Fractyl Health Receives Clinical Trial Application Authorization In Netherlands To Initiate Phase 1/2 First-in-human Study Of RJVA-001, Expects To Start Dosing And Report Preliminary Data In 2H of 2026Benzinga · May 11, 2026, 11:06 AM